Articles

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia;School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia
VU University Medical Center, Amsterdam, the Netherlands
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia
Genetic and Molecular Pathology, SA Pathology, Adelaide, Australia
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia
Genetic and Molecular Pathology, SA Pathology, Adelaide, Australia
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia;School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia;School of Biological Sciences, Faculty of Sciences, University of Adelaide, Australia;School of Paediatrics, Faculty of Health Sciences, University of Adelaide, Australia;Health Sciences UniSA, Adelaide, Australia
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia;School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia;Australasian Leukaemia and Lymphoma Group, Melbourne, Australia;Department of Haematology, Royal Adelaide Hospital and SA Pathology, Australia
School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia;Genetic and Molecular Pathology, SA Pathology, Adelaide, Australia;School of Paediatrics, Faculty of Health Sciences, University of Adelaide, Australia;Centre for Cancer Biology, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia;School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia;Australasian Leukaemia and Lymphoma Group, Melbourne, Australia;Department of Haematology, Royal Adelaide Hospital and SA Pathology, Australia;Centre for Cancer Biology, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia;School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia;Australasian Leukaemia and Lymphoma Group, Melbourne, Australia;Department of Haematology, Royal Adelaide Hospital and SA Pathology, Australia;Centre for Cancer Biology, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia;Flinders University and Medical Centre, Adelaide, Australia
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.189787